LOADING
Comparing Visa Inc (V) and Merck & Company (MRK) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | V | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $615.9B | $274.8B |
| P/E Ratio | 28.3 | 31.4 |
| Forward P/E | 24.5 | 22.0 |
| PEG Ratio | 1.67 | 5.18 |
| EPS | $11.46 | $3.55 |
| Revenue Growth (YoY) | 17.1% | 4.9% |
| Profit Margin | 51.7% | 13.6% |
| Return on Equity | 60.4% | 18.9% |
| Dividend Yield | 0.82% | 2.94% |
| Beta | 0.78 | 0.20 |
| 52-Week High | $372.56 | $124.22 |
| 52-Week Low | $293.28 | $70.74 |
| Volume | -- | -- |
Visa Inc is the larger company by market capitalization. Visa Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Visa Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.